Bajpai, Khattar continue to outperform

SMART PORTFOLIOS

Image
Rex Cano Mumbai
Last Updated : Jan 20 2013 | 11:53 PM IST

Shishir Bajpai and Vinay Khattar remained immune to the sharp market fall in the last five trading days. The relative outperformance can be attributed to their investment in Inventure Growth & Securities, which zoomed nearly 80 on debut today - August 04. The Smart Portfolios benchmark, the S&P CNX 500 index, portfolio value declined over 3 per cent to 9.50 lakh, while Bajpai saw a minor cut of 0.6 per cent in net worth, and Khattar logged a gain of 1.5 per cent. Ajay Parmar, however, who remained on the sidelines, registered a loss of 2.8 per cent in the last five days.

 

The two active fund managers - Bajpai and Khattar - took a diverse route this time around. While the former continued to churn his portfolio and remain fully invested, the latter preferred to raise his cash levels. For more details log on to smartinvestor.in/sp

 

Shishir Bajpai, Senior Vice President, IIFL Private Wealth

 

Shishir Bajpai was very active, and executed as many as 50 trades in the period under review. He booked a gain of around 10 per cent on his investment in Amrutanjan Healthcare and Wockhardt. Bajpai booked losses in most of his other exits, notable ones (10 per cent each) in India Glycols and Pantaloon Retail. His prominent fresh investments are Inventure Growth, Uflex, McLeod Russel, JSW Steel, Delta Corp, Websol Energy and Adani Enterprises. Bajpai's net worth has appreciated by 44.7 per cent to Rs 14.47 lakh in the last 11 months.

 

Vinay Khattar, Research Head - Edelweiss Wealth Management

 

Vinay Khattar, too, was fairly active with 35-odd trades. He was a net seller of stocks to the tune of Rs 4 lakh, whereby his cash limit has now increased to Rs 6 lakh. Khattar booked sharp gains in select investments like - Amrutanjan Healthcare, TTK Healthcare and Prime Focus. Orchid Chemicals, however, was one of his top loss-making investment. His prominent fresh buys are Inventure Growth, Rashtriya Chemicals & Fertilisers, Atul, Delta Corp and TTK Healthcare. Khattar's portfolio value now stands at Rs 14.59 lakh, up almost 46 per cent.

 

Ajay Parmar, Head Research Institutional Equities, Emkay

 

Ajay Parmar's net worth has declined a wee bit below the Rs 10-lakh initial corpus. His investments are valued at Rs 8.87 lakh, while he holds Rs 1.12 lakh cash. His top picks remain - eClerx Services, Jubilant Foodworks, Lovable Lingerie and Insecticides India. On the other hand, Infinite Computer Solutions, Shree Renuka Sugars, Bajaj Hindusthan, Aurobindo Pharma, Balrampur Chini, Manali Petrochemical and Walchandnagar Industries are the major laggards.

 

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Aug 05 2011 | 1:01 AM IST

Next Story